# K231325: Corplex P / Theracor P / Allacor P

- Pathway: 510(k) (Traditional)
- Applicant: Stimlabs, LLC
- Decided: Feb 2, 2024 after 270 days
- Product code: KGN (Wound Dressing With Animal-Derived Material(S))
- Device class: U
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 8 generations back to K921895 (1992). 38 ancestors in all.
3 later devices descend from it; 3 cite it directly.
0 of 42 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K200502: Myriad Particles, Aroa Biosurgery, Ltd. (2021) Summary page 4.

## Most influential descendants
- K253204: Catalyze (2026), 0 descendants of its own
- K253339: Theracor (2025), 0 descendants of its own
- K242828: Corplex P/ Theracor P/ Allacor P (2024), 0 descendants of its own

## Indications for use
Corplex P/Theracor P/Allacor P is indicated for use in the management of the following wounds: • Partial and full-thickness wounds • Pressure ulcers • Venous ulcers • Diabetic ulcers • Chronic vascular ulcers • Tunneled/undermined wounds • Surgical wounds (donor sites/grafts, post-Moh's surgery, post-laser surgery, podiatric, wound dehiscence) • Trauma wounds (abrasions, lacerations, partial-thickness burns, and skin tears) • Draining wounds

Source page: https://510kreport.com/device/K231325
Methodology: https://510kreport.com/methodology